Sunscreen slow down: The US FDA's sluggish approval of new sunscreens frustrates physicians, manufacturers, and consumers

By  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2861-2862

Blackwell Publishing

Access to resources Recommend Favorite

Clamp down on Rx drugs without US FDA approval

By  

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Is the UK government delaying approval for new cancer drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The Impact of Biomarkers and Surrogate End Points on Regulatory Approval of New Drugs

By  

Heart Drug, Vol. 2, Iss. 5, 2003-01 ,pp. : 235-245

Karger

Access to resources Recommend Favorite

New Antiviral Nucleoside Prodrugs Await Application

By  

Current Medicinal Chemistry, Vol. 10, Iss. 18, 2003-09 ,pp. : 1825-1843

Bentham Science Publishers

Access to resources Recommend Favorite